SCHEMBL30166798

SCHEMBL30166798

CC1C(=O)N(c2ccc3[nH]cnc3c2)C1c1c(F)cc(-n2cc(C(F)(F)F)cn2)cc1F

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ QPCT Q16769 20/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24815542 1.00 QPCT (0.40) QPCT
SCHEMBL24816663 1.00 QPCT (0.40) QPCT
SCHEMBL24814369 1.00 QPCT (0.40) QPCT
SCHEMBL24814371 1.00 QPCT (0.40) QPCT
SCHEMBL24815541 1.00 QPCT (0.40) QPCT
SCHEMBL26825184 0.89 QPCT (0.35) QPCT
SCHEMBL26824879 0.89 QPCT (0.35) QPCT
SCHEMBL26825186 0.89 QPCT (0.35) QPCT
SCHEMBL24814330 0.87 QPCT (0.40) QPCT
SCHEMBL30166814 0.87 QPCT (0.40) QPCT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118019737-A Beta-lactam derivatives for the treatment of diseases 英矽智能科技知识产权有限公司 2024-05-10 — — CN disclosed
EP-4359405-A1 BETA-LACTAM DERIVATIVES FOR THE TREATMENT OF DISEASES Insilico Medicine IP Limited (HK) 2024-05-01 — — EP disclosed
WO-2022268179-A1 BETA-LACTAM DERIVATIVES FOR THE TREATMENT OF DISEASES INSILICO MEDICINE IP LIMITED (CN) 2022-12-29 — — WO disclosed
Send feedback